Previous studies in prostate and breast cancers demonstrated that EGF induced AR/ER/Src association, resulting in activation of Src signaling (25,28) and that Src signals phosphorylated tyrosine residue of AR, provoking its transactivation and cell proliferation (29). Here, ESR1 is linked to breast cancer.